Artelo Biosciences Inc. (ARTL)
Artelo Biosciences Statistics
Share Statistics
Artelo Biosciences has 3.23M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 3.23M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 3.26% |
| Shares Floating | 3.2M |
| Failed to Deliver (FTD) Shares | 420 |
| FTD / Avg. Volume | 1.21% |
Short Selling Information
The latest short interest is 19.93K, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 19.93K |
| Short % of Shares Out | 0.62% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 1.65 |
Valuation Ratios
The PE ratio is -0.83 and the forward PE ratio is -2.48. Artelo Biosciences's PEG ratio is 0.02.
| PE Ratio | -0.83 |
| Forward PE | -2.48 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 0.42 |
| P/FCF Ratio | -1.02 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Artelo Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.36, with a Debt / Equity ratio of 0.
| Current Ratio | 18.36 |
| Quick Ratio | 18.36 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.32 |
| Cash Flow / Debt | -127.11 |
| Interest Coverage | -2057.4 |
Financial Efficiency
Return on equity (ROE) is -0.51% and return on capital (ROIC) is -51.75%.
| Return on Equity (ROE) | -0.51% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -51.75% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,974,800 |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -209K |
| Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -29.93% in the last 52 weeks. The beta is 1.06, so Artelo Biosciences's price volatility has been higher than the market average.
| Beta | 1.06 |
| 52-Week Price Change | -29.93% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 36.15 |
| Average Volume (20 Days) | 34.68K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -10.29M |
| Net Income | -9.87M |
| EBITDA | -10.29M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.49 |
Balance Sheet
The company has 6.89M in cash and 63K in debt, giving a net cash position of 6.83M.
| Cash & Cash Equivalents | 6.89M |
| Total Debt | 63K |
| Net Cash | 6.83M |
| Retained Earnings | -31.02M |
| Total Assets | 15.5M |
| Working Capital | 12.51M |
Cash Flow
In the last 12 months, operating cash flow was -8.01M and capital expenditures 0, giving a free cash flow of -8.01M.
| Operating Cash Flow | -8.01M |
| Capital Expenditures | 0 |
| Free Cash Flow | -8.01M |
| FCF Per Share | -2.83 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -338.83% |
| FCF Yield | -239.71% |
Analyst Forecast
The average price target for ARTL is $6, which is 482.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 482.5% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Aug 10, 2022. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 10, 2022 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -2.41 |
| Piotroski F-Score | 2 |